Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Mercedes Santoro

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
Systematic Reviews|April 27, 2020
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocolEzechiel Ngoufack Jagni Semengue, Maria Mercedes Santoro, Valantine Ngum Ndze, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 26, 2020
Marked decrease in acquired resistance to antiretrovirals in latest years in ItalyAlessia Lai, Marco Franzetti, Annalisa Bergna, et al.
Journal of Global Antimicrobial Resistance|July 15, 2023
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohortAdriana Cervo, Antonio Russo, Domenico Di Carlo, et al.
Journal of Virology|July 1, 2006
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitorsValentina Svicher, Tobias Sing, Maria Mercedes Santoro, et al.
Journal of Global Antimicrobial Resistance|August 10, 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studyMaria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, et al.
Journal of Global Antimicrobial Resistance|July 23, 2019
Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitorsRossana Scutari, Claudia Alteri, Ilaria Vicenti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 24, 2019
Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological successClaudia Alteri, Rossana Scutari, Christof Stingone, et al.
Viruses|July 29, 2020
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in ItalyLavinia Fabeni, Maria Mercedes Santoro, Patrizia Lorenzini, et al.
AIDS Patient Care and Stds|December 22, 2007
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe StudyMaria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, et al.
Open Forum Infectious Diseases|July 30, 2025
Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered QuestionsAnna Maria Geretti, Marta Boffito, Stefano Bonora, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Systematic Reviews|April 27, 2020
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocolEzechiel Ngoufack Jagni Semengue, Maria Mercedes Santoro, Valantine Ngum Ndze, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 26, 2020
Marked decrease in acquired resistance to antiretrovirals in latest years in ItalyAlessia Lai, Marco Franzetti, Annalisa Bergna, et al.
Journal of Global Antimicrobial Resistance|July 15, 2023
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohortAdriana Cervo, Antonio Russo, Domenico Di Carlo, et al.
Journal of Virology|July 1, 2006
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitorsValentina Svicher, Tobias Sing, Maria Mercedes Santoro, et al.
Journal of Global Antimicrobial Resistance|August 10, 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studyMaria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, et al.
Journal of Global Antimicrobial Resistance|July 23, 2019
Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitorsRossana Scutari, Claudia Alteri, Ilaria Vicenti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 24, 2019
Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological successClaudia Alteri, Rossana Scutari, Christof Stingone, et al.
Viruses|July 29, 2020
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in ItalyLavinia Fabeni, Maria Mercedes Santoro, Patrizia Lorenzini, et al.
AIDS Patient Care and Stds|December 22, 2007
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe StudyMaria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, et al.
Open Forum Infectious Diseases|July 30, 2025
Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered QuestionsAnna Maria Geretti, Marta Boffito, Stefano Bonora, et al.
Pageof 14